permits continuation of the phenothiazine without change of dosage
Cogentin advertisement, 1972

when extrapyramidal symptoms upset phenothiazine therapy
COGENTIN® (benztropine mesylate MSD) helps keep productive therapy from becoming counterproductive

* Helps relieve rigidity and tremor
* Provides long duration of action
* Frequently permits continuation of the phenothiazine without change of dosage
Contraindications: Children under three years of age; use cautiously in older children.
Warnings: Safe use in pregnancy not established. May impair mental and/or physical abilities required for performance of hazardous tasks,
such as operating machinery or driving a motor vehicle.
For more detailed information, consult your MSD representative or see the Direction Circular.
Merck Sharp & Dohme, Division of Merck & Co., Inc. West Point, Pa. 19486

Back to Mental Medicine Extrapyramidal scheme


© 2008 Bonkers Institute for Nearly Genuine Research